Arranta Bio, a microbiome contract development and manufacturing organisation, announced on Wednesday that it has named Shailesh Maingi as its new independent director.

Maingi is the founder and CEO of Kineticos Life Sciences and founder of the Kineticos Disruptor Fund. He has served as directors of various biotech companies, including Gallus Biopharmaceuticals and Locus Biosciences and founded InVincible Cancer Research Fund. He presently serves as an adjunct professor at the University of North Carolina at Chapel Hill.

Mark Bamforth, president and CEO at Arranta, said, 'Having known Shailesh for 10 years, I am excited to have him bring his broad industry knowledge, sharp intellect and strategic expertise to our board of directors as we build the leading microbiome CDMO.'